|Title:||Essure™ Procedure for Female Sterilisation|
|Document ID:||Operational Circular OP 1892/04|
|Date of issue:||Thursday, 23 December 2004|
|Status:||NO LONGER APPLICABLE|
|Description:||This Operational Circular advises hospitals that the Essure procedure for female sterilisation can not be used in the WA public health sector.|
|Applicable to:||Clinical and administrative staff of the Department of Health|
|Period of effect:||from 1 January 2004|
|Authorised by:||Dr Andrew Robertson, Group Director, Health Care and Disaster Preparedness, 21-Dec-2004|
|Print version:||View print version|
Essure™ Procedure for Female Sterilisation
The Essure™ procedure involves intra-uterine insertion of a prosthetic device into the fallopian tubes to stimulate fibroblast occlusion of the tubes. Abdominal incision is not required and therefore it does not involve anaesthesia or hospitalisation. Permanent occlusion takes approximately 3 months to occur and requires confirmation by ultrasound. The success of the procedure is unpredictable due to individual anatomical variation, and the long-term effectiveness is not yet known 1,2. There is a need for practitioners to be trained and credentialled.
The total costs for this procedure are substantially greater than other sterilisation procedures currently provided within the public hospital system. Alternatives are available for most women. Essure™ sterilisation cannot be made available for use in the public hospital system at this time.
The decision may be reviewed subject to the following:
Dr Andrew Robertson
This circular last updated: Thursday, 23 December 2004 at 12:00am